Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-10-14

Clinical Trial Update: Effect of Intravesical Lidocaine on Urodynamic and Symptomatic Parameters of Interstitial Cystitis [NA]

View source ↗

Summary

A clinical trial examining the effects of intravesical lidocaine on urodynamic and symptomatic measures in interstitial cystitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine (Lidocaine)

Snippet

Sponsor: Northwell Health | Conditions: Interstitial Cystitis | NA | Status: WITHDRAWN